RxDoctor Payments Data

Anand Haryani

MOHS-Micrographic Surgery · Sebastian, FLNPI 1861812851

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Galderma Laboratories, L.p. at 36.2% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in FL, where the typical reported total is $1,790.

$1,747in general payments, 2019–2025

Across 71 payments — averaging $24.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$632
  • Organogenesis Inc.$496
  • AbbVie$154
  • Solta Medical, A Division Of Bausch Health US, LLC$109
  • Boston Scientific$77
  • Strata Skin Sciences, Inc.$50
  • plus $229 from 10 others
$174,069in research payments, 2019–2025

Across 10 payments — averaging $17,407 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$174K

What the payments were for

  • Food & beverage$1,747100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,747 in reported general payments places this provider in the 45th percentile of 141 mohs-micrographic surgery providers in Florida.

See all mohs-micrographic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$2,734,509
Medicare patients
1,260
Services billed
22,116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab39$147,565
Clobetasol Propionate111$6,086
SantylCollagenase Clostridium Hist.11$4,349
Ketoconazole168$2,858
Fluocinonide36$2,544
Doxycycline Hyclate142$2,510
Triamcinolone Acetonide183$1,889
Cephalexin251$1,647
Fluorouracil25$1,611
Metronidazole42$1,591
Dutasteride53$1,093
Fluocinolone Acetonide27$1,082
Mupirocin126$921
Clindamycin Phosphate36$804
ValacyclovirValacyclovir Hcl69$618

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Sebastian

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →